Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk)
ADT-Netzwerk is a German nonprofit network organization that coordinates clinical cancer registries and oncology centers nationwide, standardizing cancer data via the oBDS framework and operating certification programs, biennial quality conferences, and AI-supported research platforms for the German oncology ecosystem.
- Company typePrivate
- Founded1983
- HeadquartersBerlin, Germany
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) does
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) is a German registered nonprofit association (eingetragener Verein) headquartered in Berlin that operates as the coordinating network for clinical cancer registries and oncology centers across Germany. Founded in 1978 (per firmographic records) or 1983 (per company history), the organization standardizes cancer registration through the Bundeseinheitlicher Onkologischer Basisdatensatz (oBDS) and operates a trust office (Vertrauensstelle) for secure data handling. ADT co-initiated the German National Cancer Plan and holds legal recognition under §65c of the cancer registration framework, giving it a central role in shaping national oncology quality standards.
The organization's core offerings are a 20-day certification program for tumor documentation specialists (Tumordokumentar/in), jointly developed with DVMD and GEKID; the biennial Bundesweite Onkologische Qualitätskonferenz (BOQK) conference series, which has analyzed over 5 million patient records across 21 tumor entities since 2006; the Onkologie im Dialog event series co-organized with Deutsche Krebsgesellschaft; the Plattform-Lösung zur Datenzusammenführung (Stufe 2) for cross-registry data consolidation; and the onkoFDZ cancer research data center for AI-supported evidence generation. An over-90-person interdisciplinary evaluation team conducts the biennial analyses.
ADT's business model combines institutional membership fees with training and event fees. Pricing is modest and tiered by membership status: Onkologie im Dialog events are €50 for non-members and free for members, the 20-day certification is €1,000 per complete block or €200 per individual module, and a research prize endowed at €2,000 is jointly awarded with DNVF. The organization serves clinical cancer registries, certified oncological centers, the German Cancer Consortium (CCC-Netzwerk), tumor documentation professionals, oncology researchers, and patient advocacy organizations, with operational reach confined to Germany and revenue not publicly disclosed.
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) firmographics
Firmographics- Name
- Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk)
- Legal name
- Arbeitsgemeinschaft Deutscher Tumorzentren e.V.
- Website
- https://adt-netzwerk.de
- Company type
- Private
- Founded year
- 1983
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- ADT-Netzwerk is a German nonprofit network organization that coordinates clinical cancer registries and oncology centers nationwide, standardizing cancer data via the oBDS framework and operating certification programs, biennial quality conferences, and AI-supported research platforms for the German oncology ecosystem.
- Ownership category
- akta.pro rank
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) industry classification
Industry- Product category
- Oncology Quality Assurance
- SIC
- Services-Membership Organizations (8600)
- akta.pro primary industry
- Disease Registries (Cancer, Immunization, Rare Disease, etc.) (HLAJAJAE)
- akta.pro secondary industry
- Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ)
Keywords
Where Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Membership Fees: Annual membership fees for tumor centers, cancer registries, and oncology institutions to access the network, training programs, and member-exclusive pricing on events.
- Training and Event Fees: Fees for educational programs including the 20-day certification series (Block I-IV at €1,000 per complete block or €200 per individual module), individual training sessions, and event registrations. Onkologie im Dialog events are priced at €50 for non-members and free for members.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | One-time | Onkologie im Dialog 2026 |
| Unit Pricing | One-time | Block III - 20-day training series (complete) |
| Other | One-time | Research Prize |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) product offering
Product offeringCore offering
ADT-Netzwerk is a registered nonprofit association that coordinates Germany's nationwide network of clinical cancer registries and oncological centers. Its core offerings include a 20-day certified training program for tumor documentation specialists, biennial national oncology quality conferences (Bundesweite Onkologische Qualitätskonferenz), collaborative events between registries and centers (Onkologie im Dialog), research data platforms (onkoFDZ, Plattform-Lösung Stufe 2), and the Bundeseinheitlicher Onkologischer Basisdatensatz (oBDS) data standard with XML interface for cancer registration.
Product overview
ADT-Netzwerk operates as a network organization focused on oncology quality, care, and research. The core offerings include a structured educational program (20-day training series with certification 'Tumordokumentar/in'), annual conferences (Bundesweite Onkologische Qualitätskonferenz since 2006, Onkologie im Dialog events), research platforms (Plattform-Lösung Stufe 2 for data integration, onkoFDZ for AI-supported research), and standardized data systems (Bundeseinheitlicher Onkologischer Basisdatensatz with XML interface). The organization functions as a coordinating and quality assurance body for German cancer registries rather than a software product company.
Differentiator
Problem solved
Functional benefit
Products and services
- Fortbildungsreihe in der Krebsregistrierung/Tumordokumentation A 20-day structured training series in cancer registration and tumor documentation delivered in one-week blocks, intended for medical documentation professionals, cancer registrars, and health information managers.
- Zertifikat 'Tumordokumentar/in' A professional certification awarded after completion of the 20-day training series and a supervised examination, intended for tumor documentation and cancer registry professionals.
- Bundesweite Onkologische Qualitätskonferenz (BOQK) A biennial conference series presenting register-based analyses of cancer treatment outcomes, therapy decisions, and guideline implementation across up to 21 cancer entities, drawing on more than 5 million patient records from 2000–2024.
- Onkologie im Dialog An event series co-organized with Deutsche Krebsgesellschaft for practical exchange between clinical cancer registries and oncology centers, covering data quality, feedback processes, and digital interfaces.
- Plattform-Lösung zur Datenzusammenführung (Stufe 2) A platform solution enabling consolidation and harmonized analysis of cancer registry data from multiple sources to support cross-registry research projects.
- Krebsforschungsdatenzentrum (onkoFDZ) A cancer research data center providing infrastructure for AI-supported evidence generation from healthcare-proximate (real-world) cancer registry data.
- Prüfungsvorbereitungsportal An online examination preparation portal for the Tumordokumentar/in certification, offering practice exercises and statistics tutorials.
- Bundeseinheitlicher Onkologischer Basisdatensatz (oBDS) A standardized national oncology basic dataset with an XML interface for cancer registration, providing documentation manuals and classification standards for use by German cancer registries.
Quantifiable outcome
- Analysis of over 5 million cancer patient records across 21 tumor entities in the 2025/2026 evaluation cycle
- +1 more outcomes
Companies that use Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk)
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and major.
- Deutsche Krebsgesellschaft e.V. (German Cancer Society)coreCo-organizer of the 'Onkologie im Dialog' event series alongside ADT, focused on collaboration between clinical cancer registries and oncological centers. The partnership addresses quality, feedback, and utilization of registry data, as well as digital interfaces and common standards. Also collaborates on quality conferences and research initiatives.
- § 65c Plattform (Platform for Clinical Cancer Registries)coreCollaborative platform for Germany's clinical cancer registries operating under §65c of the cancer registration law. ADT collaborates on national quality conferences, platform solutions for data aggregation (Stufe 2), and research initiatives. Tobias Hartz from the platform presented at the 2026 Onkologie im Dialog event.
- Deutsches Netzwerk für Versorgungsforschung (DNVF)majorCo-awards the annual 'Preis für Forschung mit versorgungsnahen Daten in der Onkologie' (Research Prize for Real-World Data Research in Oncology), endowed at €2,000. The joint jury includes members from both organizations. Prize ceremony takes place at the German Congress for Health Services Research (DKVF).
- Haus der Krebs-Selbsthilfe – Bundesverband e.V.majorNational cancer self-help umbrella organization representing patient interests. Participates in quality conferences providing patient perspective on oncology care. Contributes to discussions on utilizing real-world data for practice improvement.
- Stiftung Deutsche Krebshilfe (German Cancer Aid Foundation)majorGermany's largest independent cancer charity. Participates in quality conferences contributing to discussions on evidence generation and care improvement in oncology. Represented in balance and outlook sessions.
- Fachverband für Dokumentation und Informationsmanagement in der Medizin (DVMD)coreProfessional association for medical documentation and information management. Co-developed the joint certificate 'Tumordokumentar/in' alongside ADT and GEKID, establishing competency standards for tumor documentation professionals in Germany.
- Gesellschaft der epidemiologischen Krebsregister in Deutschland (GEKID)coreSociety of German epidemiological cancer registries. Co-developed the joint certificate 'Tumordokumentar/in' alongside ADT and DVMD. Represents the epidemiological cancer registry perspective in professional training standards.
- CCC-Netzwerk (German Cancer Consortium - Network of Comprehensive Cancer Centers)majorNetwork of German Comprehensive Cancer Centers. Collaborates through initiatives like 'ONCOnnect' to share best practices. Featured at 'Onkologie im Dialog' events for presenting ONCOnnect best practice examples.
- Bundesministerium für Gesundheit (German Federal Ministry of Health)coreFederal ministry responsible for health policy. Sends greetings/address at major ADT events (e.g., Philipp Müller from Abteilung 5 at 20 Jahre BOQK event), indicating government recognition and support for the organization's quality improvement mission.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) competitors and assessment
Company assessmentEmerging players
- Tempus AI: U.S. AI-driven precision medicine and oncology RWE company. Emerging player peer applying AI/ML to oncology clinical and molecular data — overlapping with ADT's onkoFDZ AI-supported evidence generation objectives.
- Flatiron Health: U.S. oncology real-world evidence company (Roche). Emerging player peer because it builds large-scale deidentified oncology datasets and AI-supported evidence generation — directly competing with ADT's onkoFDZ mission in the commercial RWE space.
Direct peers
- Fachverband für Dokumentation und Informationsmanagement in der Medizin (DVMD): German professional association for medical documentation and information management. Direct peer that co-developed the Tumordokumentar/in certification with ADT and addresses overlapping training and standards-setting activities.
- Gesellschaft der epidemiologischen Krebsregister in Deutschland (GEKID): Society of German epidemiological cancer registries. Direct peer because GEKID partners with ADT on certification (Tumordokumentar/in) and operates complementary cancer registry functions in the same German ecosystem.
- Robert Koch Institute (RKI) - Zentrum für Krebsregisterdaten: Germany's federal public health institute housing the Center for Cancer Registry Data. Direct peer because RKI aggregates and publishes national cancer registry data — a closely overlapping mandate with ADT's coordination of clinical cancer registries.
- Deutsche Krebsgesellschaft (DKG): German Cancer Society. Direct peer that co-organizes the 'Onkologie im Dialog' series with ADT and drives oncology certification standards (Onkologische Zentren, CCCs), addressing overlapping member institutions and quality frameworks.
Broad incumbents
- Stiftung Deutsche Krebshilfe: Germany's largest independent cancer charity. Broad incumbent because it funds cancer research, participates in quality conferences, and convenes CCC network activities, overlapping with ADT's ecosystem role.
- International Agency for Research on Cancer (IARC): WHO's cancer research agency operating global cancer registry initiatives (e.g., CI5, CanReg5). Broad incumbent in cancer registry data collection, harmonization, and international comparability — analogous to ADT's national coordination role.
- National Cancer Institute - SEER Program: U.S. NCI's Surveillance, Epidemiology, and End Results program. Broad incumbent peer running a national cancer registry and RWE infrastructure with comparable scope and ambition to ADT's German network.
Regional players
- European Cancer Information System (ECIS) / JRC: EU Joint Research Centre's European Cancer Information System aggregating cancer registry data across member states. Regional player that complements ADT's German registry mission at the European level.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) social profiles
Digital presenceArbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) financial estimates
Financial estimateRevenue estimate
Valuation estimate
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) leadership team
Management profileNumber of profiles
Profiles11 records
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk)
What does Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) do?
ADT-Netzwerk is a registered nonprofit association that coordinates Germany's nationwide network of clinical cancer registries and oncological centers. Its core offerings include a 20-day certified training program for tumor documentation specialists, biennial national oncology quality conferences (Bundesweite Onkologische Qualitätskonferenz), collaborative events between registries and centers (Onkologie im Dialog), research data platforms (onkoFDZ, Plattform-Lösung Stufe 2), and the Bundeseinheitlicher Onkologischer Basisdatensatz (oBDS) data standard with XML interface for cancer registration.
Is Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) a public or private company?
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) founded?
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) was founded in 1983. It employs 1 to 10 people.
Where is Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) based?
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) is headquartered in Berlin, Germany, in the Europe region.
How does Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) make money?
Two revenue lines are on record. Membership Fees are the primary driver. The others are training and Event Fees.
Who are Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk)'s main competitors?
Emerging players on record are Tempus AI and Flatiron Health. Direct peers are Fachverband für Dokumentation und Informationsmanagement in der Medizin (DVMD), Gesellschaft der epidemiologischen Krebsregister in Deutschland (GEKID), Robert Koch Institute (RKI) - Zentrum für Krebsregisterdaten and Deutsche Krebsgesellschaft (DKG). Broad incumbents are Stiftung Deutsche Krebshilfe, International Agency for Research on Cancer (IARC) and National Cancer Institute - SEER Program. European Cancer Information System (ECIS) / JRC is listed as a regional player.
Does Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) have an API?
No public API is recorded for Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk).
What industry is Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk) in?
Arbeitsgemeinschaft Deutscher Tumorzentren e.V. (ADT-Netzwerk)'s product category is Oncology Quality Assurance. Its primary akta.pro industry code is HLAJAJAE, Disease Registries (Cancer, Immunization, Rare Disease, etc.), with a secondary code of HLACAMAJ, Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces. Its SIC code is 8600.